Soy protein containing isoflavones favorably influences macrophage lipoprotein metabolism but not the development of atherosclerosis in CETP transgenic mice

Lipids

Volumn 41, Issue 7, 2006, Pages 655-662

  Asakura, Leiko ^a   Cazita, Patricia M ^a   Harada, Lila M ^a   Nunes, Valéria S ^a   Berti, Jairo A ^b   Salerno, Alessandro G ^b   Ketelhuth, Daniel F J ^a   Gidlund, Magnus ^a   Oliveira, Helena C F ^b   Quintão, Eder C R ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c University of São Paulo ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CETP TRANSGENIC MICE; LIPOPROTEIN METABOLISM; SOY PROTEINS;

ACETYLATION; BIODIVERSITY; CHOLESTEROL; GENES; LIPIDS; METABOLISM;

PROTEINS;

APOLIPOPROTEIN B; AUTOANTIBODY; CHOLESTEROL ESTER TRANSFER PROTEIN; CHOLESTEROL OLEATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SOYBEAN PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; AORTA ATHEROSCLEROSIS; AORTA ROOT; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL ESTERIFICATION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; LIPID DIET; LIPOPROTEIN METABOLISM; MALE; MOUSE; NONHUMAN; OVARIECTOMY; PERITONEUM MACROPHAGE; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ATHEROSCLEROSIS; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GLYCOPROTEINS; HETEROZYGOTE; HUMANS; ISOFLAVONES; LIPIDS; LIPOPROTEINS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVARIECTOMY; RECEPTORS, LDL; SOYBEAN PROTEINS; TRANSGENES;

MUS MUSCULUS;

EID: 33749610798     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-006-5016-7     Document Type: Article

References (47)

1. Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S., Newby, L.K., Waters, D., Vittinghoff, E., and Wenger, N. (2002) HERS Research Group. Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II), JAMA 288, 49-57.
2. Hulley, S., Furberg, C., Barrett-Connor, E., Cauley, J., Grady, D., Haskell, W., Knopp, R., Lowery, M., Satterfield, S., Schrott, H., Vittinghoff, E., and Hunninghake, D. (2002) HERS Research Group. Noncardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II), JAMA 288, 58-66.
3. Writing Group for the Women's Health Initiative Investigators. (2002) Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results from the Women's Health Initiative Randomized Controlled Trial, JAMA 288, 321-333.
4. Zhuo, X.G., Melby, M.K., and Watanabe, S. (2004) Soy Isoflavone Intake Lowers Serum LDL Cholesterol: A Meta-analysis of Eight Randomized Controlled Trials in Humans, J. Nutr. 134, 2395-2400.
5. Albertazzi, P., Pansini, F., Bonaccorsi, G., Zanotti, L., Forini, E., and De Aloysio, D. (1998) The Effect of Dietary Soy Supplementation on Hot Flushes, Obstet. Gynecol. 91, 96-11.
6. Crisafulli, A., Marini, H., Bitto, A., Altavilla, D., Squadrito, G., Romeo, A., Adamo, E.B., Marini, R., D'Anna, R., Corrado, F., Bartolone, S., Frisina, N., and Squadrito, F. (2004) Effects of Genistein on Hot Flushes in Early Postmenopausal Women: A Randomized, Double-Blind EPT- and Placebo-Controlled Study, Menopause 11, 400-404.
7. Horiuchi, T., Onouchi, T., Takahashi, M., Ito, H., and Orimo, H. (2000) Effect of Soy Protein on Bone Metabolism in Postmenopausal Japanese Women, Osteoporos. Int. 11, 721-724.
8. Cassidy, A., and Griffin, B. (1999) Phyto-oestrogens: A Potential Role in the Prevention of CHD? Proc. Nutr. Soc. 58, 193-199.
9. Vitolins, M.Z., Anthony, M., and Burke, G.L. (2001) Soy Protein Isoflavones, Lipids and Arterial Disease, Curr. Opin. Lipidol. 12, 437-437.
10. Sacks, P.M., Lichtenstein, A., Van Horn, L., Harris, W., Kris-Etherton, P., and Winston, M. American Heart Association Nutrition Committee. (2006) Soy Protein, Isoflavones, and Cardiovascular Health: An American Heart Association Science Advisory for Professionals from the Nutrition Committee, Circulation 113, 1034-1044.
11. Van der Schouw, Y.T., Kreijkamp-Kaspers, S., Peeters, P.H., Keinan-Boker, L., Rimm, E.B., and Grobee, D.E. (2005) Prospective Study on Usual Dietary Phytoestrogen Intake and Cardiovascular Disease Risk in Western Women, Circulation 111, 466-471.
12. Clarkson, T.B. (2002) Soy, Soy Phytoestrogens and Cardiovascular Disease, J. Nutr. 132, 66S-569S.
13. Anderson, J.W., Johnsotone, B.M., and Cook-Newell, M.E. (1995) Meta-analysis of the Effects of Soy Protein Intake on Serum Lipids, N. Engl. J. Med. 333, 276-282.
14. Engelman, H.M., Alekel, D.L., Hanson, L.N., Kanthasamy, A.G., and Reddy, M.B. (2005) Blood Lipid and Oxidative Stress Responses to Soy Protein with Isoflavones and Phytic Acid in Postmenopausal Women, Am. J. Clin. Nutr. 81, 590-596.
15. Kreijkamp-Kaspers, S., Kok, L., Grobbee, D.E., de Haan, E.H., Aleman, A., Lampe, J.W., and Van der Schouw, Y.T. (2004) Effect of Soy Protein Containing Isoflavones on Cognitive Function, Bone Mineral Density, and Plasma Lipids in Postmenopausal Women: A Randomized Controlled Trial, JAMA 292, 65-74.
16. Clarkson, T.B., Anthony, M.S., and Morgan, T.M. (2001) Inhibition of Postmenopausal Atherosclerosis Progression: A Comparison of the Effects of Conjugated Equine Estrogens and Soy Phytoestrogens, J. Clin. Endocrinol. Metab. 86, 41-47.
17. Lucas, E.A., Lightfoot, S.A., Hammond, L.J., Devareddy, L., Khalil, D.A., Daggy, B.P., Soung do, Y., and Arjmandi, B.H. (2003) Soy Isoflavones Prevent Ovariectomy-Induced Atherosclerotic Lesions in Golden Syrian Hamster Model of Postmenopausal Hyperlipidemia, Menopause 10, 314-321.
18. Kirk, E.A., Sutherland, P., Wang, S.A., Chait, A., and LeBoueuf, R.C. (1998) Dietary Isoflavones Reduce Plasma Cholesterol and Atherosclerosis in C57BL/6 Mice but Not LDL Receptor-Deficient Mice, J. Nutr. 128, 954-959.
19. Adams, M.R., Golden, D.L., Register, T.C., Anthony, M.S., Hodgin, J.B., Maeda, N., and Williams, J.K. (2002) The Atheroprotective Effect of Dietary Soy Isoflavones in Apolipoprotein E-/- Mice Requires the Presence of Estrogen Receptor-Alpha, Arterioscler. Thromb. Vasc. Biol. 22, 1859-1864.
20. Yamakoshi, J., Piskula, M.K., Izumi, T., Tobe, K., Saito, M., Kataoka, S., Obata, A., and Kikuchi, M. (2000) Isoflavone Aglycone-Rich Extract Without Soy Protein Attenuates Atherosclerosis Development in Cholesterol-Fed Rabbits, J. Nutr. 130, 1887-1893.
21. Adams, M.R., Golden, D.L., Franke, A.A., Potter, S.M., Smith, H.S., and Anthony, M.S. (2004) Dietary Soy Beta-Conglycinin (7S Globulin) Inhibits Atherosclerosis in Mice, J. Nutr. 134, 511-516.
22. Mortensen, A., Pilegaard, K., Frandsen, H., and Breinholt, V. (2004) Effect of a Soy Supplement on Spontaneous Atherosclerosis in Low Density Lipoprotein Receptor Knockout (LDLR-/-) Mice, Asia Pac. J. Clin. Nutr. 13(Suppl.), S102 (abs).
23. Wagner, J.D., Schwenke, D.C., Greaves, K.A., Zhang, L., Anthony, M.S., Blair, R.M., Shadoan, M.K., and Willianms, J.K. (2003) Soy Protein with Isoflavones, but Not Isoflavone-Rich Supplement, Improves Arterial Low-Density Lipoprotein Metabolism and Atherogenesis, Arterioscler. Thromb. Vasc. Biol. 23, 2241-2246.
24. Adams, M.R., Golden, D.L., Anthony, M.S., Register, T.C., and Williams J.K. (2002) The Inhibitory Effect of Soy Protein Isolate on Atherosclerosis in Mice Does Not Require the Presence of LDL Receptors or Alteration of Plasma Lipoproteins, J. Nutr. 132, 43-49.
25. Alexandersen, P., Haarbo, J., Breinholt, V., and Christiansen, C. (2001) Dietary Phytoestrogens and Estrogen Inhibit Experimental Atherosclerosis, Climacteric. 4, 151-159.
26. Cassidy, A., De Pascual, T.S., and Rimbach, G. (2003) Molecular Mechanisms by Dietary Isoflavones Potentially Prevent Atherosclerosis, Expert Rev. Mol. Med. 5, 1-15.
27. Meng, Q.H., Lewis, P., Wahala, K., Adlercreutz, H., and Tikkanen, M. (1992) Incorporation of Esterified Soybean Isoflavones with Antioxidant Activity into Low Density Lipoprotein, Biochim. Biophys. Acta 1438, 369-376.
28. Cazita, P.M., Berti, J.A., Aoki, C., Gidlund, M., Harada, L.M., Nunes, V.S., Quintão, B.C., and Oliveira, H.C. (2003) Cholesteryl Ester Transfer Protein Expression Attenuates Atherosclerosis in Ovariectomized Mice, J. Lipid Res. 44, 33-40.
29. Casquero, A.C., Berti, J.A., Salerno, A.G., Bighetti, E.J., Cazita, P.M., Ketelhuth, D.F., Gidlund, M., and Oliveira, H.C. (2006) Atherosclerosis Is Enhanced by Testosterone Deficiency and Attenuated by CETP Expression in Transgenic Mice, J. Lipid Res. 47, 1526-1534.
30. Paigen, B., Morrow, A., Holmes, P.A., Mitchell, D., and Willians, R.A. (1987) Quantitative Assessment of Atherosclerotic Lesions Mice, Atherosclerosis 68, 231-240.
31. Rubin, E.M., Krauss, R.M., Spangler, E.A., Verstuyft, J.G., and Glift, S.M. (1991) Inhibition of Early Atherogenesis in Transgenic Mice by Human Apolipoprotein AI, Nature 353, 265-267.
32. Damasceno, N.R., Goto, H., Rodrigues, F.M., Dias, C.T., Okawabata, F.S., Abdalla, D.S., and Gidlund, M. (2000) Soy Protein Isolate Reduces the Oxidizability of LDL and the Generation of Oxidized LDL Auto Antibodies in Rabbits with Diet-Induced Atherosclerosis, J. Nutr. 130, 2641-2647.
33. Brown, M.S., and Goldstein, J.L. (1983) Lipoprotein Metabolism in the Macrophage: Implications for Cholesterol Deposition in Atherosclerosis, Annu. Rev. Biochem. 52, 223-261.
34. Basu, S.K., Goldstein, J.L., Anderson, G.W., and Brown, M.S. (1976) Degradation of Cationized Low Density Lipoprotein and Regulation of Cholesterol Metabolism in Homozygous Familial Hypercholesterolemia Fibroblasts, Proc. Natl. Acad. Sci. USA 73, 3178-3182.
35. Dobiasova, M., Stribrna, J., Pritchard, P.H., and Frohlich, J.J. (1992) Cholesterol Esterification Rate in Plasma Depleted of Very Low and Low Density Lipoproteins Is Controlled by the Proportion of HDL2 and HDL3 Subclasses: Study in Hypertensive and Normal Middle-Aged and Septuagenarian Men, J. Lipid Res. 33, 1411-1418.
36. Tsimikas, S., Palinski, W., and Witztum, J.L. (2001) Circulating Autoantibodies to Oxidized LDL Correlate with Arterial Accumulation and Depletion of Oxidized LDL in LDL Receptor-Deficient Mice, Arterioscler. Thromb. Vasc. Biol. 21, 95-100.
37. Ehara, S., Ueda, M., Naruko, T., Haze, K., Itoh, A., Otsuka, M., Komatsu, R., Matsuo, T., Itabe, H., Takano, T., Tsukamoto, Y., Yoshiyama, M., Takeuchi, K., Yoshikawa, J., and Becker, A.E. (2001) Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship with the Severity of Acute Coronary Syndromes, Circulation 103, 1955-1960.
38. Heikkinen, A.M., Niskanen, L., Yla-Herttuala, S., Luoma, J., Tuppurainen, M.T., Komulainen, M., and Saarikoski, S. (1998) Postmenopausal Hormone Replacement Therapy and Autoantibodies Against Oxidized LDL, Maturitas 29, 155-161.
39. Uint, L., Gebara, O.C.E., Pinto, L.B., Wajngarten, M., Boschov, P., da Luz, P.L., and Gidlund, M. (2003) Hormone Replacement Therapy Increases Levels of Antibodies Against Heat Shock Protein 65 and Certain Species of Oxidized Low Density Lipoprotein, Braz. J. Med. Biol. Res. 36, 491-494.
40. Wen, Y., Doyle, M.C.T., Cooke, T., and Feeley, J. (2000) Effect of Menopause on Low-Density Lipoprotein Oxidation: Is Estrogen an Important Determinant? Maturitas 34, 233-238.
41. Santanam, N., Sher-Brewer, R., McClatchey, R., Castellano, P.Z., Murphy, A.A., Voelkel, S., and Parthasarathy, S. (1998) Estradiol as an Antioxidant: Incompatible with Its Physiological Concentrations and Function, J. Lipid Res. 39, 2111-2118.
42. Samman, S., Wall, P.M.L., Chan, G.S.M., Smith, S.J., and Petocz, P. (1999) The Effect of Supplementation with Isoflavones on Plasma Lipids and Oxidisability of Low Density Lipoprotein in Premenopausal Women, Atherosclerosis 147, 277-283.
43. Barter, P.J., and Kastelein, J.J. (2006) Targeting Cholesteryl Ester Transfer Protein for the Prevention and Management of Cardiovascular Disease, J. Am. Coll. Cardiol. 47(3), 492-499.
44. Hodgin, J.B., and Maeda, N. (2002) Estrogen and Mouse Models of Atherosclerosis, Endocrinology 143, 4495-4501.
45. Clair, R.S., and Anthony, M. (2005) Soy, Isoflavones and Atherosclerosis. Handb. Exp. Pharmacol. 170, 301-323.
46. van der Schouw, Y.T., de Kleijn, M.J., Peeters, P.H., and Grobbee, D.E. (2000) Phyto-oestrogens and Cardiovascular Disease Risk, Nutr. Metab. Cardiovasc. Dis. 10, 154-167.
47. Cassidy, A., and Hooper, L. (2006) Phytoestrogens and Cardiovascular Disease, J. Br. Menopause Soc. 12, 49-56.